1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Research and Development Trend Forecast of Chinese Patent Medicine in China, 2014-2018

Please note: The report is Chinese version. It will provide the English version in two business days.

Research and Development Trend Forecast of Chinese Patent Medicine in China, 2014-2018 analyses the policy environment, market scale, competition pattern, development trend and key enterprises in Chinese patent medicine industry in China.

The implement of New Medical Reform Plan provides solid guarantee for the development of Chinese patent medicine, but also National Essential Drugs List lists large batch of Chinese Patent Medicine, which drives the continual expansion of Chinese patent medicine market scale in China effectively. In 2009, the cumulative output of Chinese patent medicine was 1.8037 million ton, since 2010, the Chinese patent medicine industry has been maintaining fast growth, the cumulative output was 1.9977 million ton in 2010 and 3.1052 million ton in 2013.

With the era development, the health concept has been given new connotation, the third state (Sub-health state) and its harm has cause people’s extensive concerns; and with the improvement of living standard, people long for life quality and long life increasingly. Human medical model has been transformed from the pure “biomedical model” to the “biological-psychology-sociological model”, and from treatment of disease to the model combining prevention, health, treatment and recovery.

The chemical drugs bite off more than they can chew in this field, while the profound Chinese patent medicine are causing people’s attention and playing important role in health increasingly, and the rush of health cult provides valuable opportunities and extensive space for Chinese patent medicine development in China.

Table Of Contents

Research and Development Trend Forecast of Chinese Patent Medicine in China, 2014-2018
1. Overview of Chinese Patent Medicine
1.1 Concept
1.2 Product Classification

2. Development Environment of Chinese Patent Medicine in China
2.1 Economic Development Environment in China
2.2 Related Industrial Policies, Law, Regulations and Standards
2.2.1 Influence on Chinese Patent Medicine by New Medical Reform Policy
2.2.2 Chinese Patent Medicine Development in “the 12th Five Years Plan” Period
2.2.3 Policy Summary of Medicine Industry in China
2.2.4 Related Industrial Standards
2.3 Many Countries with Restriction on Sales of Chinese Patent Medicine

3. Current Status of Chinese Patent Medicine Industry in China
3.1 Development History
3.2 Current Status of Overall Development
3.2.1 Current Status of Chinese Patent Medicine Development in China
3.2.2 Current Status of Chinese Patent Medicine Trade in China
3.3 Competition Pattern in Chinese Patent Medicine Industry

4. Analysis and Forecast on Chinese Patent Medicine Market Scale in China
4.1 Output
4.1.1 Output Analysis
4.1.2 Output Forecast
4.2 Sales
4.2.1 Sales Analysis
4.2.2 Sales Structure in 2013
4.2.3 Sales Forecast
4.3 Market Segmentation
4.3.1 Cardio-cerebrovascular Diseases
4.3.2 Tumor diseases
4.3.3 Respiratory Diseases
4.3.4 Bone Diseases

5. Analysis on Import and Export of Chinese Patent Medicine in China
5.1 Import Volume and Value in 2011- the First Half Year of 2014
5.2 Export Volume and Value in 2011- the First Half Year of 2014
5.3 Main Import Sources and Export Destinations by Trade Value in the First Half Year of 2014

6. Main Chinese Patent Medicine Enterprises in China
6.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd
6.1.1 Company Profile
6.1.2 Competitiveness
6.1.3 Business Performance
6.1.4 Development Strategy
6.1.5 Main Business and Products
6.2 Jilin Xiuzheng Pharmaceutical Group
6.2.1 Company Profile
6.2.2 Competitiveness
6.2.3 Business Performance
6.2.4 Main Products
6.3 Yangtze River Pharmaceutical Group
6.3.1 Company Profile
6.3.2 Competitiveness
6.3.3 Business Performance
6.3.4 Development Strategy
6.3.5 Main Products
6.4 Chongqing Taiji Industry (Group) Co., Ltd
6.4.1 Company Profile
6.4.2 Competitiveness
6.4.3 Business Performance
6.4.4 Development Strategy
6.4.5 Main Products
6.5 China Resources Sanjiu Medical and Pharmaceutical Co., Ltd
6.5.1 Company Profile
6.5.2 Competitiveness
6.5.3 Business Performance
6.5.4 Development Strategy
6.5.5 Main Business and Products

7. Future Development Trend of Chinese Patent Medicine in China

8. Expert Suggestion on investment in Chinese Patent Medicine Industry
8.1 SWOT Analysis
8.2 Market Strategy Analysis

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.